FPT-CORPORATION
16.4.2024 08:23:31 CEST | Business Wire | Press release
As part of its ongoing commitment to the highest standards of sustainable development, FPT Corporation (FPT) has published its ESG report and prioritized ESG as a key aspect of its 2024 development strategy. The report highlights FPT’s achievement of 87% positive employee feedback, certified by Great Place to Work® - a significantly higher rating than a typical global company’s average of 53%. The Corporation is also certified among Vietnam's Top 10 Best Large-Scale Workplaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240415745348/en/
Happy Run race is one of FPT’s social responsibility activities (Photo: Business Wire)
“In 2023, I described FPT as a joyful sanctuary. I delineated the concept wherein FPT assumed the role of building a happier future for shareholders, customers, and employees. This depiction has begun to manifest itself into reality,” said FPT Chairman Dr. Truong Gia Binh.
FPT’s ESG commitment is reflected in four key areas: Work Environment, Environmental Sustainability, Social Responsibility, and Excellent Governance, with actions taking references from Global Reporting Initiative (GRI) Standards and 17 Sustainable Development Goals of the United Nations.
Building on the core values of "Respect - Innovation - Cohesion - Equality - Exemplarity - Lucidity," FPT is committed to creating a happy, diverse, and inclusive workplace. The Corporation has employees from 73 nationalities, with women representing 37.4% of the total workforce and 36.1% of managerial roles.
In 2023, the number of foreign employees at FPT increased by 67% year-on-year to 2,925, including senior-level members from such companies as Airbus, SCSK, Tata Consultancy Services, and HCL. FPT also recorded a decade-low turnover rate of 10.3% and a 13.6% increase in the total workforce compared to 2022. “We prioritize building a cohesive, family-like atmosphere where leaders and employees regard one another as family. In times of adversity, we stand together and never leave anyone behind,” FPT Chairman Dr. Truong Gia Binh added.
Social responsibility forms an integral part of FPT's culture. In 2023, FPT donated VND 205.2 billion (approximately $8.2 million) to social responsibility activities, benefiting over 83,753 people in Vietnam. The company's first global Happy Run race attracted 191,000 participants, raising VND 3.6 billion (approximately $145,000) to build schools in remote areas. Hope School - FPT’s initiative to support children orphaned by COVID-19 - has continued to ensure a safe and comprehensive learning environment for 230 students from 41 provinces, with a new construction set to be completed in 2024.
The Corporation also demonstrates its strong commitment to environmental conservation and the ambitious goal of becoming the pioneering company in Vietnam to achieve Net Zero emissions by 2040. FPT has been applying various measures to minimize environmental impact by reducing energy consumption and greenhouse gas emissions, such as monitoring 100% of energy usage data and replacing 100% of office waste bags with recyclable materials, while ensuring all employees receive annual training on environmental protection policy.
Regarding corporate governance, FPT pledges to build and maintain a governance framework including charter, regulations, process handbooks, and regulatory documents across the Corporation to ensure a professional, effective and disciplined governance system from the Corporation to its subsidiaries.
Vertical functional management and centralized data management serve as the "backbone" of FPT's efforts to optimize its management and operations, as well as fostering sustainable growth. The Corporation also conducted internal digital transformation projects, with 42 being implemented in 2023 to ensure cost savings, optimize operations, and improve experience for both employees and customers.
About FPT Corporation
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of US$2.17 billion and 48,000+ employees. For more information, please visit https://fpt.com.vn/en.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240415745348/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
